Maravai Lifesciences Holdings (MRVI) EPS (Weighted Average and Diluted) (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly EPS (Weighted Average and Diluted) of -$0.02 in Q1 2026, up 91.67% quarter-over-quarter from -$0.24 in Q4 2025, and up 90.48% on a YoY basis from -$0.01 in Q1 2025.
Maravai Lifesciences Holdings (MRVI) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at -$0.02 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 90.48% year-over-year to -$0.02; the TTM figure through Mar 2026 stood at -$0.71 (up 37.72% YoY), while the FY2025 annual figure was -$0.9, up 14.29% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.02 for Q1 2026 at Maravai Lifesciences Holdings, up from -$0.24 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.53 in Q2 2022 to a low of -$0.8 in Q4 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.07 across 5 years, with a median of -$0.07 in 2024.
- The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) soared 108.33% in 2022, then sank 1260.0% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.3 in 2022, then plunged by 366.67% to -$0.8 in 2023, then surged by 77.5% to -$0.18 in 2024, then sank by 33.33% to -$0.24 in 2025, then surged by 91.67% to -$0.02 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.02 (Q1 2026), -$0.24 (Q4 2025), and -$0.18 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 0.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.61 |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.18 |
| Jun 30, 2025 | -0.27 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | -0.68 |
| Jun 30, 2024 | -0.07 |
| Mar 31, 2024 | -0.09 |
| Dec 31, 2023 | -0.80 |
| Sep 30, 2023 | -0.05 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | 0.30 |
| Sep 30, 2022 | 0.34 |
| Jun 30, 2022 | 0.53 |
| Mar 31, 2022 | 0.50 |
| Dec 31, 2021 | 0.43 |
| Sep 30, 2021 | 0.44 |
| Jun 30, 2021 | 0.44 |